Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles

The authors explored whether the direct reduction of therapy sensitivity induced by stroma-produced paracrine factors contributed to the link between stroma and poor responses to chemotherapies.